The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 08, 2020
Filed:
Jun. 10, 2016
Applicants:
Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;
Centre National DE LA Recherche Scientifique—cnrs, Paris, FR;
Universite Pierre ET Marie Curie (Paris 6), Paris, FR;
Inventors:
Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); G01N 33/68 (2006.01); C07K 14/47 (2006.01); A61P 25/28 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
A61K 48/00 (2013.01); A61P 25/28 (2018.01); C07K 14/4711 (2013.01); C12Q 1/6883 (2013.01); G01N 33/6896 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0312 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/46 (2013.01); G01N 2800/2821 (2013.01);
Abstract
The invention relates to the use of HNRNPC-expressing vectors for preventing and/or treating a tauopathy, such as Alzheimer's disease. The invention relates to methods for detecting a risk of developing a tauopathy such Alzheimer's disease in a patient, comprising the step of detecting the level of HNRNPC in a biological sample obtained from said patient.